Zimmer Biomet Expands Orthopedic Capabilities with Monogram Technologies Acquisition

Zimmer Biomet Holdings, a globally recognized leader in medical technology, has announced the successful acquisition of Monogram Technologies. This strategic move positions Zimmer Biomet to significantly enhance its orthopedic robotics portfolio and navigate the future of surgical innovations.

On October 7, 2025, Zimmer Biomet completed the acquisition of Monogram Technologies, a pioneering company in AI-driven orthopedic robotics. Monogram specializes in semi- and fully autonomous robotic technologies that promise to revolutionize surgical procedures in orthopedics. This acquisition is not a mere expansion; it is a bold step towards providing the first fully autonomous robotic solution in the orthopedic field, according to Ivan Tornos, Zimmer Biomet's Chairman, President, and CEO. His commitment to innovation ensures that the company will continue to be at the forefront of orthopedic surgery.

With the integration of Monogram, Zimmer Biomet aims to offer surgeons a wider selection of robotics and navigation systems across a diverse range of procedures. This acquisition not only strengthens Zimmer Biomet’s market position but also deepens its commitment to improving surgical outcomes through advanced technological solutions. Tornos emphasized the importance of Monogram's talent and technology as a catalyst to accelerate the company’s innovation pipeline.

Enhanced Technology Offerings

Monogram has developed innovative robotic technology for total knee arthroplasty (TKA) that utilizes CT-based, AI-navigated systems. This technology has already received FDA clearance in March 2025 and is expected to be available commercially alongside Zimmer Biomet implants by early 2027. In an exciting development, Monogram is also conducting clinical studies for its fully autonomous robotic technology, which further reinforces Zimmer Biomet’s strategy to lead in this market.

The addition of Monogram's capabilities broadens Zimmer Biomet's already impressive suite of orthopedic robotics and solutions. Their existing offerings include imageless robotic systems, mixed reality navigation, and AI-powered tools, which are essential in enhancing surgical precision and improving patient outcomes. With nearly 2,000 installations of the ROSA® Robotics platform globally, Zimmer Biomet is not only a leader in the U.S. but is also advancing rapidly in international markets.

Strategic Growth and Investment

Zimmer Biomet's commitment to the evolution of its robotics platform demonstrates its dedication to continuous innovation. The company has established a robust research and development pipeline, with several new products and software applications anticipated between now and 2027. Key upcoming technologies include ROSA Knee with OptimiZe™, which has recently been submitted for FDA clearance. This future-focused approach underscores Zimmer Biomet's determination to remain a pivotal player in orthopedic medicine.

The acquisition also encompasses financial dynamics; as per the merger agreement, each outstanding share of Monogram was converted into a cash payment along with contingent value rights. These rights offer potential additional compensation tied to future product milestones and revenues. Furthermore, upon completion of the acquisition, Monogram ceased trading on NASDAQ, transitioning into a new phase under the Zimmer Biomet umbrella.

Conclusion

Zimmer Biomet’s acquisition of Monogram Technologies marks a significant milestone in the medical technology landscape, particularly in the realm of orthopedic surgery. By combining their extensive resources, innovation capabilities, and commitment to improving patient care, Zimmer Biomet is poised to redefine the future of robotic-assisted surgery, paving the way for advancements that will benefit both surgeons and patients alike. With this acquisition, Zimmer Biomet does not simply add to its portfolio—it positions itself as a leader in the continuously evolving field of medical technology.

For more insights into Zimmer Biomet's innovative solutions and extensive product offerings, visit Zimmer Biomet's official website.